[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100503013":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":20,"locations":26,"responsibleParty":63,"collaborators":19,"id":65,"slug":19,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":69,"acronym":19,"eligibilityCriteria":70,"healthyVolunteers":66,"sex":71,"minAge":72,"maxAge":19,"enrollmentInfo":73,"targetDuration":19,"studyType":76,"phases":77,"briefSummary":79,"conditions":80,"keywords":82,"overallStatus":29,"whyStopped":19,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"Aptissen SA","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"SYNOLIS VA 80\u002F160","EXPERIMENTAL","Single guided intra-articular injection of SYNOLIS VA 80\u002F160",[13],"Device: SYNOLIS VA 80\u002F160",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"DEVICE","SYNOLIS VA 80\u002F160 (hyaluronic acid 80 mg, sorbitol 160 mg)",[9],null,[21],{"name":22,"role":23,"phone":24,"phoneExt":19,"email":25},"Eduard Vidovic, MD","CONTACT","+41225522104","clinic@aptissen.com",[27,41,52],{"facility":28,"status":29,"city":30,"state":19,"zip":19,"country":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"Service de Rhumatologie, Hôpital Nord Franche-Comté","RECRUITING","Belfort","France",{"type":33,"coordinates":34},"Point",[35,36],6.85385,47.64218,{"lat":36,"lon":35},[39],{"name":40,"role":23,"phone":19,"phoneExt":19,"email":19},"Thierry Conrozier, Dr",{"facility":42,"status":29,"city":43,"state":19,"zip":19,"country":31,"cosmosGeoPoint":44,"geoPoint":48,"contacts":49},"Service de chirurgie orthopédique et traumatologie Centre Hospitalier de Dunkerque CHD","Dunkirk",{"type":33,"coordinates":45},[46,47],2.37681,51.0344,{"lat":47,"lon":46},[50],{"name":51,"role":23,"phone":19,"phoneExt":19,"email":19},"Nicolas Jan, Dr",{"facility":53,"status":29,"city":54,"state":19,"zip":19,"country":31,"cosmosGeoPoint":55,"geoPoint":59,"contacts":60},"Service d'Orthopédie II (Membre Inférieur, Chirurgie du Sport et Chirurgie Septique) Hôpital Salengro, CHRU de Lille","Lille",{"type":33,"coordinates":56},[57,58],3.05512,50.63391,{"lat":58,"lon":57},[61],{"name":62,"role":23,"phone":19,"phoneExt":19,"email":19},"Henri Migaud, Pr",{"type":64,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR","100503013",false,"NCT05829733","6-month Efficacy and Safety of Synolis VA 80\u002F160 in Hip Osteoarthritis","6-month Evaluation of the Efficacy and Safety of Synolis VA 80\u002F160 in the Treatment of Symptomatic Hip Osteoarthritis","Inclusion Criteria:\n\n* Patient over 18 years of age,\n* Patient with osteoarthritis of the hip. The diagnosis is based on the following criteria:\n* Treated hip pain: Oxford score ≥ 21\u002F60,\n* Kellgren-Lawrence positive X-ray stage: II - III (inclusion radiograph dated no more than 6 months before the inclusion visit),\n* Symptoms related to osteoarthritis of the hip for at least 2 months,\n* Failure of treatments (i.e., inadequate or ineffective response to analgesics and\u002For NSAIDs or intolerance to NSAIDs or low-grade opioids (leaving an OXFORD score ≥ 21\u002F60),\n* Informed consent form signed by the patient,\n* The patient has never had a visco supplement injection or corticosteroid injection in the hip to be treated (or more than 6 months old).\n\nExclusion Criteria:\n\n* Pregnancy,\n* Participation in another clinical trial,\n* Skin lesion near the injection site,\n* Recent or old infection of the affected joint,\n* Patient with a programmed arthroplasty,\n* Patient with a pathology that makes decision-making impossible,\n* The patient must not have undergone non-prosthetic hip-conserving surgery such as osteotomy or arthroscopy less than 12 months old.","ALL","18 Years",{"count":74,"type":75},70,"ESTIMATED","INTERVENTIONAL",[78],"NA","Multicenter, independent study of Synolis VA 80\u002F160 over a period of 6 months",[81],"Osteoarthritis, Hip",[83,84,85],"Osteoarthritis","Hip osteoarthritis","Hyaluronic acid","2025-12-05",{"date":88,"type":89},"2025-12-12","ACTUAL",{"date":91,"type":89},"2024-05-27",{"date":93,"type":75},"2027-04",{"name":5,"class":6},3]